ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,383Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 823

$609K Total Retail Price of All Prescriptions

Rank: 68 out of 823

439 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 9,760 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 570 507 1 6
HYDROCODONE-ACETAMINOPHEN 478 370 S3 2 1
SIMVASTATIN 342 297 3 2
LISINOPRIL 331 274 4 4
POTASSIUM CHLORIDE 286 257 5 22
FUROSEMIDE 276 248 6 7
AMLODIPINE BESYLATE 256 235 7 3
OMEPRAZOLE 239 209 8 5
GLIMEPIRIDE 211 195 9 51
METOPROLOL TARTRATE 207 185 10 11
CITALOPRAM HBR 200 152 11 34
HYDROCHLOROTHIAZIDE 190 177 12 29
METFORMIN HCL 175 150 13 14
SERTRALINE HCL 168 120 14 38
ATORVASTATIN CALCIUM 164 157 15 13
AZITHROMYCIN 137 118 16 48
CLOPIDOGREL 129 109 17 16
CRESTOR 119 101 18 20
ATENOLOL 118 106 19 47
PREDNISONE 113 107 20 31
METOPROLOL SUCCINATE 111 103 21 9
ZOLPIDEM TARTRATE 110 83 22 17
TRAMADOL HCL 110 107 22 15
ISOSORBIDE MONONITRATE ER 108 82 24 49
NEXIUM 107 85 25 10
WARFARIN SODIUM 99 99 26 18
TAMSULOSIN HCL 98 87 27 21
CYCLOBENZAPRINE HCL 97 39 R 28 63
GABAPENTIN 92 69 29 8
CIPROFLOXACIN HCL 89 74 30 32
TRICOR 85 79 31 150
CYMBALTA 84 74 32 40
BISOPROLOL-HYDROCHLOROTHIAZIDE 82 68 33 164
TRAZODONE HCL 81 58 34 43
CLONIDINE HCL 78 75 35 41
PLAVIX 77 68 36 25
DONEPEZIL HCL 75 75 37 24
MELOXICAM 74 54 38 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 64 39 39
TRIAMTERENE-HCTZ 71 60 40 138
LOVASTATIN 70 56 41 132
AMITRIPTYLINE HCL 69 61 R 42 89
FLUTICASONE PROPIONATE 66 59 43 50
PRAVASTATIN SODIUM 64 54 44 23
DIGOXIN 63 62 45 33
GLYBURIDE 61 41 R 46 150
PAROXETINE HCL 61 42 46 175
PANTOPRAZOLE SODIUM 60 52 48 30
AMOXICILLIN 60 39 48 207
VENLAFAXINE HCL ER 59 52 50 163
ALLOPURINOL 59 50 50 61
LANTUS 58 44 52 76
BISOPROLOL FUMARATE 58 51 52 216
ALENDRONATE SODIUM 57 56 54 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.